Liquidmetal® Technologies, Inc. (OTCQB: LQMT), the world's leading developer of amorphous alloys, received an annual purchase order to produce a critical medical device component for CoNextions, a medical device developer and manufacturer. The significant order was received on heels of Liquidmetal having recently completed production tooling and the delivery of initial parts on a very aggressive timeline.

"We are thrilled to have been selected by CoNextions as a key supplier and to have the opportunity to demonstrate the capabilities of our technology and outstanding engineering and manufacturing team," said Paul Hauck, Vice President of World-Wide Sales and Marketing. "Liquidmetal was asked to complete production tooling and initial parts against a challenging schedule. Our ability to meet their demanding timeline is a reflection of what can happen through close collaboration between two companies and having highly talented and committed professionals in both organizations."

About Liquidmetal TechnologiesLiquidmetal Technologies, Inc. is the leading developer of amorphous alloys that utilize the performance advantages offered by amorphous alloy technology. Amorphous alloys are unique materials that are distinguished by their ability to retain a random structure when they solidify, in contrast to the crystalline atomic structure that forms in ordinary metals and alloys. Liquidmetal Technologies is the first company to produce amorphous alloys in commercially viable bulk form, enabling significant improvements in products across a wide array of industries. For more information, go to

About CoNextionsFounded in 2011, CoNextions Medical, Inc. is a privately held company located in Sandy, Utah. They are an innovation-based medical device company dedicated to achieving safer, stronger, and more durable tendon repairs worldwide marked by faster rehabilitation, fewer complications and lower long-term costs.

For additional information about CoNextions Medical or the CoNextions TR, contact Angela Bailey, at (801) 580-4049 or

View source version on

Copyright Business Wire 2010